307 related articles for article (PubMed ID: 31041299)
61. Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement.
Jin X; Xu Y; Zhang J; Li G; Huang D; Yang Y; He H
Diagn Pathol; 2017 Jun; 12(1):46. PubMed ID: 28623913
[TBL] [Abstract][Full Text] [Related]
62. Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma.
Kim HS; Kim KH; Kim KH; Chang MH; Ji SH; Lim DH; Kim K; Kim SJ; Ko Y; Ki CS; Jo SJ; Lee JW; Kim WS
Leuk Lymphoma; 2009 May; 50(5):757-63. PubMed ID: 19330658
[TBL] [Abstract][Full Text] [Related]
63. Extranodal NK/T-Cell Lymphoma, Nasal Type, Presenting as a Breast Mass.
Rahal A; Reddy PS; Alvares C
Cureus; 2015 Dec; 7(12):e408. PubMed ID: 26824008
[TBL] [Abstract][Full Text] [Related]
64. Adoptive transfer of Epstein-Barr virus-specific cytotoxic T-lymphocytes for the treatment of angiocentric lymphomas.
Cho HI; Hong YS; Lee MA; Kim EK; Yoon SH; Kim CC; Kim TG
Int J Hematol; 2006 Jan; 83(1):66-73. PubMed ID: 16443556
[TBL] [Abstract][Full Text] [Related]
65. Brain Abscess as a Rare Complication of Primary Extranodal Nasal-type Natural Killer/T-cell Lymphoma.
Ohta N; Waki T; Ito T; Suzuki Y; Kakehata S; Aoyagi M
Yonago Acta Med; 2020 Feb; 63(1):88-91. PubMed ID: 32158338
[TBL] [Abstract][Full Text] [Related]
66. Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders.
de Mel S; Tan JZ; Jeyasekharan AD; Chng WJ; Ng SB
Front Pediatr; 2018; 6():405. PubMed ID: 30705877
[TBL] [Abstract][Full Text] [Related]
67. Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases.
Kato S; Takahashi E; Asano N; Tanaka T; Megahed N; Kinoshita T; Nakamura S
Histopathology; 2012 Aug; 61(2):186-99. PubMed ID: 22690710
[TBL] [Abstract][Full Text] [Related]
68. Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma.
Suzuki R
Semin Hematol; 2014 Jan; 51(1):42-51. PubMed ID: 24468315
[TBL] [Abstract][Full Text] [Related]
69. Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK/T-cell lymphoma.
Ishii H; Ogino T; Berger C; Köchli-Schmitz N; Nagato T; Takahara M; Nadal D; Harabuchi Y
J Med Virol; 2007 May; 79(5):562-72. PubMed ID: 17385697
[TBL] [Abstract][Full Text] [Related]
70. [Clinical, phenotypic and genotypic aspects of nasal T-cell lymphoma and its causal association with Epstein-Barr virus].
Harabuchi Y; Imai S; Kataura A; Osato T
Nihon Rinsho; 1997 Feb; 55(2):394-9. PubMed ID: 9046830
[TBL] [Abstract][Full Text] [Related]
71. Nodal presentation of nasal-type NK/T-cell lymphoma. Report of two cases with fine needle aspiration cytology findings.
Ng WK; Lee CY; Li AS; Cheung LK
Acta Cytol; 2003; 47(6):1063-8. PubMed ID: 14674081
[TBL] [Abstract][Full Text] [Related]
72. Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases.
Takahashi E; Asano N; Li C; Tanaka T; Shimada K; Shimada S; Yoshino T; Kojima M; Hara K; Eimoto T; Nakamura S
Histopathology; 2008 Apr; 52(5):585-96. PubMed ID: 18370955
[TBL] [Abstract][Full Text] [Related]
73. Diagnosis and management of natural killer-cell malignancies.
Ishida F; Kwong YL
Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
[TBL] [Abstract][Full Text] [Related]
74. Natural killer-cell malignancies: diagnosis and treatment.
Kwong YL
Leukemia; 2005 Dec; 19(12):2186-94. PubMed ID: 16179910
[TBL] [Abstract][Full Text] [Related]
75. Recent advances in the diagnosis and treatment of natural killer/T-cell lymphomas.
Tse E; Au-Yeung R; Kwong YL
Expert Rev Hematol; 2019 Nov; 12(11):927-935. PubMed ID: 31487202
[No Abstract] [Full Text] [Related]
76. Cutaneous presentation of nasal/nasal type T/NK cell lymphoma: clinicopathological findings of four cases.
Miyamoto T; Yoshino T; Takehisa T; Hagari Y; Mihara M
Br J Dermatol; 1998 Sep; 139(3):481-7. PubMed ID: 9767295
[TBL] [Abstract][Full Text] [Related]
77. Clinicopathological analysis of 12 patients with Epstein-Barr virus-positive primary intestinal T/natural killer-cell lymphoma (EBV
Hu LM; Takata K; Miyata-Takata T; Asano N; Takahashi E; Furukawa K; Miyoshi H; Satou A; Kohno K; Kosugi H; Kinoshita T; Hirooka Y; Goto H; Nakamura S; Kato S
Histopathology; 2017 Jun; 70(7):1052-1063. PubMed ID: 28120384
[TBL] [Abstract][Full Text] [Related]
78. Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.
Haverkos BM; Pan Z; Gru AA; Freud AG; Rabinovitch R; Xu-Welliver M; Otto B; Barrionuevo C; Baiocchi RA; Rochford R; Porcu P
Curr Hematol Malig Rep; 2016 Dec; 11(6):514-527. PubMed ID: 27778143
[TBL] [Abstract][Full Text] [Related]
79. Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course.
Mraz-Gernhard S; Natkunam Y; Hoppe RT; LeBoit P; Kohler S; Kim YH
J Clin Oncol; 2001 Apr; 19(8):2179-88. PubMed ID: 11304770
[TBL] [Abstract][Full Text] [Related]
80. Cutaneous peripheral T-cell lymphoma of cytotoxic phenotype mimicking extranodal NK/T-cell lymphoma.
Pan ST; Chang WS; Murphy M; Martinez A; Chuang SS
Am J Dermatopathol; 2011 Apr; 33(2):e17-20. PubMed ID: 21252637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
